| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3883428
[patent_doc_number] => 05833977
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Method of improving the quality of plant seeds using lactic acid producing micro-organisms'
[patent_app_type] => 1
[patent_app_number] => 8/765931
[patent_app_country] => US
[patent_app_date] => 1997-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5458
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/833/05833977.pdf
[firstpage_image] =>[orig_patent_app_number] => 765931
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/765931 | Method of improving the quality of plant seeds using lactic acid producing micro-organisms | Jan 13, 1997 | Issued |
Array
(
[id] => 3785485
[patent_doc_number] => 05840575
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'DNA ladders'
[patent_app_type] => 1
[patent_app_number] => 8/781866
[patent_app_country] => US
[patent_app_date] => 1997-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 2993
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840575.pdf
[firstpage_image] =>[orig_patent_app_number] => 781866
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/781866 | DNA ladders | Jan 9, 1997 | Issued |
Array
(
[id] => 1531736
[patent_doc_number] => 06410224
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Ribozyme treatment of diseases or conditions related to levels of NF-B'
[patent_app_type] => B1
[patent_app_number] => 08/777916
[patent_app_country] => US
[patent_app_date] => 1996-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20486
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410224.pdf
[firstpage_image] =>[orig_patent_app_number] => 08777916
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/777916 | Ribozyme treatment of diseases or conditions related to levels of NF-B | Dec 22, 1996 | Issued |
Array
(
[id] => 4180262
[patent_doc_number] => 06150092
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Antisense nucleic acid compound targeted to VEGF'
[patent_app_type] => 1
[patent_app_number] => 8/765340
[patent_app_country] => US
[patent_app_date] => 1996-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22442
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150092.pdf
[firstpage_image] =>[orig_patent_app_number] => 765340
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/765340 | Antisense nucleic acid compound targeted to VEGF | Dec 22, 1996 | Issued |
Array
(
[id] => 3994829
[patent_doc_number] => 05922539
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Methods for use of mismatch repair systems for the detection and removal of mutant sequences that arise during enzymatic amplification'
[patent_app_type] => 1
[patent_app_number] => 8/767258
[patent_app_country] => US
[patent_app_date] => 1996-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9713
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922539.pdf
[firstpage_image] =>[orig_patent_app_number] => 767258
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/767258 | Methods for use of mismatch repair systems for the detection and removal of mutant sequences that arise during enzymatic amplification | Dec 12, 1996 | Issued |
Array
(
[id] => 3882416
[patent_doc_number] => 05776685
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Protein kinase C assay'
[patent_app_type] => 1
[patent_app_number] => 8/752047
[patent_app_country] => US
[patent_app_date] => 1996-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10472
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776685.pdf
[firstpage_image] =>[orig_patent_app_number] => 752047
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/752047 | Protein kinase C assay | Nov 18, 1996 | Issued |
Array
(
[id] => 1506833
[patent_doc_number] => 06440660
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Oligonucleotide mediated reversal of drug resistance'
[patent_app_type] => B1
[patent_app_number] => 08/745485
[patent_app_country] => US
[patent_app_date] => 1996-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11860
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440660.pdf
[firstpage_image] =>[orig_patent_app_number] => 08745485
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/745485 | Oligonucleotide mediated reversal of drug resistance | Nov 11, 1996 | Issued |
| 08/744211 | REAGENTS AND METHODS USEFUL FOR DETECTING LUNG DISEASE | Nov 4, 1996 | Abandoned |
Array
(
[id] => 3780646
[patent_doc_number] => 05821062
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Oligonucleotide for use in checking presence or absence of mutation in human-derived cytochrome P450IIC18 gene'
[patent_app_type] => 1
[patent_app_number] => 8/716459
[patent_app_country] => US
[patent_app_date] => 1996-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 7791
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821062.pdf
[firstpage_image] =>[orig_patent_app_number] => 716459
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/716459 | Oligonucleotide for use in checking presence or absence of mutation in human-derived cytochrome P450IIC18 gene | Nov 4, 1996 | Issued |
Array
(
[id] => 4179736
[patent_doc_number] => 06020144
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-01
[patent_title] => 'Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same'
[patent_app_type] => 1
[patent_app_number] => 8/735507
[patent_app_country] => US
[patent_app_date] => 1996-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19894
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/020/06020144.pdf
[firstpage_image] =>[orig_patent_app_number] => 735507
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/735507 | Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same | Oct 22, 1996 | Issued |
| 08/702724 | INHIBITION OF CELL PROLIFERATION BY E2F-1 ANTISENSE OLIGONUCLEOTIDES | Oct 16, 1996 | Abandoned |
Array
(
[id] => 3995481
[patent_doc_number] => 05922583
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Methods for production of recombinant plasmids'
[patent_app_type] => 1
[patent_app_number] => 8/732612
[patent_app_country] => US
[patent_app_date] => 1996-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10607
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922583.pdf
[firstpage_image] =>[orig_patent_app_number] => 732612
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/732612 | Methods for production of recombinant plasmids | Oct 15, 1996 | Issued |
Array
(
[id] => 4049804
[patent_doc_number] => 05932417
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Method of screening compounds for controlling capacitative calcium ion entry into mammalian cells'
[patent_app_type] => 1
[patent_app_number] => 8/729955
[patent_app_country] => US
[patent_app_date] => 1996-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17527
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932417.pdf
[firstpage_image] =>[orig_patent_app_number] => 729955
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/729955 | Method of screening compounds for controlling capacitative calcium ion entry into mammalian cells | Oct 14, 1996 | Issued |
Array
(
[id] => 4188717
[patent_doc_number] => 06093806
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'DNA encoding proteins of Kaposi\'s sarcoma associated herpesvirus'
[patent_app_type] => 1
[patent_app_number] => 8/728603
[patent_app_country] => US
[patent_app_date] => 1996-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 14718
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093806.pdf
[firstpage_image] =>[orig_patent_app_number] => 728603
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/728603 | DNA encoding proteins of Kaposi's sarcoma associated herpesvirus | Oct 9, 1996 | Issued |
| 08/731199 | ANTISENSE OLIGONUCLEOTIDE MODULATION OF MDR P-GLYCOPROTEIN GENE EXPRESSION | Oct 3, 1996 | Abandoned |
Array
(
[id] => 3768744
[patent_doc_number] => 05756310
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'CDNA encoding a human phospholemman-like protein (HPLP)'
[patent_app_type] => 1
[patent_app_number] => 8/725531
[patent_app_country] => US
[patent_app_date] => 1996-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16401
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756310.pdf
[firstpage_image] =>[orig_patent_app_number] => 725531
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/725531 | CDNA encoding a human phospholemman-like protein (HPLP) | Oct 2, 1996 | Issued |
Array
(
[id] => 4199184
[patent_doc_number] => 06013660
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-11
[patent_title] => 'Externally targeted prophylactic and chemotherapeutic method and agents'
[patent_app_type] => 1
[patent_app_number] => 8/724814
[patent_app_country] => US
[patent_app_date] => 1996-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 15894
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/013/06013660.pdf
[firstpage_image] =>[orig_patent_app_number] => 724814
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/724814 | Externally targeted prophylactic and chemotherapeutic method and agents | Oct 1, 1996 | Issued |
| 08/722116 | METHODS OF TREATING EUKARYOTIC CELLS | Sep 17, 1996 | Abandoned |
Array
(
[id] => 4038001
[patent_doc_number] => 05856435
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Nucleic acid-containing composition, its preparation and use'
[patent_app_type] => 1
[patent_app_number] => 8/687551
[patent_app_country] => US
[patent_app_date] => 1996-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5823
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856435.pdf
[firstpage_image] =>[orig_patent_app_number] => 687551
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/687551 | Nucleic acid-containing composition, its preparation and use | Aug 25, 1996 | Issued |
Array
(
[id] => 1484671
[patent_doc_number] => 06365345
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role'
[patent_app_type] => B1
[patent_app_number] => 08/666341
[patent_app_country] => US
[patent_app_date] => 1996-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2572
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365345.pdf
[firstpage_image] =>[orig_patent_app_number] => 08666341
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/666341 | Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role | Aug 14, 1996 | Issued |